Biomarkers in veterinary cancer screening: Applications, limitations and expectations

Veterinary Journal

Volumn 185, Issue 1, 2010, Pages 10-14

  Henry, Carolyn J ^a  

^a UNIVERSITY OF MISSOURI   (United States)

Author keywords

Biomarkers; Cancer; Diagnosis; Oncology; Veterinary

Indexed keywords

BIOLOGICAL MARKER; GLUTATHIONE TRANSFERASE; PROLINE DIPEPTIDASE; THYMIDINE KINASE 1; TRIOSEPHOSPHATE ISOMERASE; TUMOR MARKER;

ANTIGEN DETECTION; B CELL LYMPHOMA; BLOOD ANALYSIS; CANCER DIAGNOSIS; CANCER RISK; CANCER SCREENING; CLINICAL PRACTICE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DOG DISEASE; EARLY DIAGNOSIS; EVIDENCE BASED MEDICINE; GOLD STANDARD; HUMAN; ION EXCHANGE CHROMATOGRAPHY; LYMPHOMA; NONHUMAN; POLYMERASE CHAIN REACTION; REVIEW; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; SYSTEMATIC ERROR; VETERINARY MEDICINE; ANIMAL; DISEASE COURSE; GENETICS; NEOPLASMS; ONCOLOGY; PROGNOSIS; TRENDS; VETERINARY;

ANIMALS; DISEASE PROGRESSION; EARLY DETECTION OF CANCER; MEDICAL ONCOLOGY; NEOPLASMS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL; VETERINARY MEDICINE;

ANIMALIA;

EID: 77953670526     PISSN: 10900233     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tvjl.2010.04.005     Document Type: Review

References (36)

1. Borjesson D.L., Christopher M.M., Ling G.V. Detection of canine transitional cell carcinoma using a bladder tumor antigen urine dipstick test. Veterinary Clinical Pathology 1999, 28:33-38.
2. Brawley O.W., Kramer B.S. Cancer screening in theory and in practice. Journal of Clinical Oncology 2005, 23:293-300.
3. Dickerson B.D., Geist B.L., Spillman W.B., Robertson J.L. Canine cancer screening via ultraviolet absorbance and fluorescence spectroscopy of serum proteins. Applied Optics 2007, 46:8080-8088.
4. Doherty M.K., Beynon R.J., Whitfield P.D. Proteomics and naturally occurring animal diseases: opportunities for animal and human medicine. Proteomics - Clinical Applications 2008, 2:135-141.
5. Etzioni R., Penson D.F., Legler J.M., di Tommaso D., Boer R., Gann P.H., Feuer E.J. Overdiagnosis due to prostate-specific antigen screening: lessons from US prostate cancer incidence trends. Journal of the National Cancer Institute 2002, 94:981.
6. Gaines P.J. Identification of serum biomarkers for canine B-cell lymphoma by use of surface-enhanced laser desorption-ionization time-of-flight mass spectrometry. American Journal of Veterinary Research 2007, 68:405-410.
7. Hahn K.A., Freeman K.P., Barnhill M.A., Stephen E.L. Serum a1-acid glycoprotein concentrations before and after relapse in dogs with lymphoma treated with doxorubicin. Journal of the American Veterinary Medical Association 1999, 214:1023-1025.
8. Henry C.J., Tyler J.W., McEntee M.C., Stokol T., Rogers K.S., Chun R., Garrett L.D., Higginbotham M.L., Flessland K.A., Stokes P.K. Evaluation of a bladder tumor antigen test as a screening test for transitional cell carcinoma of the lower urinary tract in dogs. American Journal of Veterinary Research 2003, 64:1017-1020.
9. Karayannopoulou M., Koutinas A.F., Polizopoulou Z.S., Roubies N., Fytianou A., Saridomichelakis M.N., Kaldrymidou E. Total serum alkaline phosphatase activity in dogs with mammary neoplasms: a prospective study on 79 natural cases. Journal of Veterinary Medicine A. Physiology, Pathology, Clinical Medicine 2003, 50:501-505.
10. Karayannopoulou M., Polizopoulou Z.S., Koutinas A.F., Fytianou A., Roubies N., Kaldrymidou E., Tsioli V., Patsikas M.N., Constantinidis T.C., Koutinas C.K. Serum alkaline phosphatase isoenzyme activities in canine malignant mammary neoplasms with and without osseous transformation. Veterinary Clinical Pathology 2006, 35:287-290.
11. Lamb C.R. Statistical briefing - sensitivity and specificity. Veterinary Radiology and Ultrasound 2007, 48:189.
12. Lamb C.R. Statistical briefing: SpPIns and SnNOouts. Veterinary Radiology and Ultrasound 2007, 48:486-487.
13. Lana S.E., Jackson T.L., Burnett R.C., Morley P.S., Avery A.C. Utility of polymerase change reaction for analysis of antigen receptor rearrangement in staging and predicting prognosis in dogs with lymphoma. Journal of Veterinary Internal Medicine 2006, 20:329-334.
14. Marconato L., Crispino G., Finotello R., Mazzotti S., Salerni F., Zini E. Serum lactate dehydrogenase activity in canine malignancies. Veterinary and Comparative Oncology 2009, 7:236-243.
15. Matharoo-Ball B., Miles A.K., Creaser C.S., Ball G., Rees R. Serum biomarker profiling in cancer studies: a question of standardization?. Veterinary and Comparative Oncology 2008, 6:224-247.
16. McCaw D.L., Chan A.S., Stegner A.L., Mooney B., Bryan J.N., Turnquist S.E., Henry C.J., Alexander H., Alexander S. Proteomics of canine lymphoma identifies potential cancer-specific protein markers. Clinical Cancer Research 2007, 13:2496-2503.
17. Merlo A., Rezende B.C., Franchini M.L., Simoes D.M., Lucas S.R. Serum C-reactive protein concentrations in dogs with multicentric lymphoma undergoing chemotherapy. Journal of the American Veterinary Medical Association 2007, 230:522-526.
18. Merlo A., Rezende B.C.G., Franchini M.L., Monterio P.R.G., Lucas S.R.R. Serum amyloid A is not a marker for relapse of multicentric lymphoma in dogs. Veterinary Clinical Pathology 2008, 37:79-85.
19. Mian S., Slater K., Cave T. The future of biomarkers and personalized medicine in companion animal practice. European Journal of Companion Animal Practice 2006, 16:63-71.
20. Mischke R., Waterston M., Eckersall P.D. Changes in C-reactive protein and haptoglobin in dogs with lymphatic neoplasia. The Veterinary Journal 2007, 174:188-192.
21. Nakumura N., Momoi Y., Watari T., Yoshino T., Tsujimoto H., Hasegawa A. Plasma thymidine kinase activity in dogs with lymphoma and leukemia. Journal of Veterinary Medical Science 1997, 59:957-960.
22. Nelson H.D., Tyne K., Naik A., Bougatsos C., Chan B.K., Humphrey L. Screening for breast cancer: an update for the US Preventive Services Task Force. Annals of Internal Medicine 2009, 151:727-737.
23. Ogilvie G.K., Walters L.M., Greeley S.G., Henkel S.E., Salman M.D. Concentration of alpha 1-acid glycoprotein in dogs with malignant neoplasia. Journal of the American Veterinary Medical Association 1993, 203:1144-1146.
24. Palka J.A., Phang J.M. Prolidase in human breast cancer MCF-7 cells. Cancer Letters 1998, 127:63-70.
25. Palka J., Surazynski A., Karna E., Orlowski K., Puchalski Z., Pruszynski K., Laszkiewicz J., Dzienis H. Prolidase activity disregulation in chronic pancreatitis and pancreatic cancer. Hepato-Gastroenterology 2002, 49:1699-1703.
26. Partridge A.H., Winer E.P. On mammography - more agreement than disagreement. New England Journal of Medicine 2009, 361:2499-2501.
27. Poli A., Arispici M., Camillo F., Corazza M. Increase of serum lipid-associated sialic acid concentration in dogs with neoplasms. American Journal of Veterinary Research 1986, 47:607-609.
28. Ratcliffe L., Mian S., Slater K., King H., Napolitano M., Aucoin D., Mobasheri A. Proteomic identification and profiling of canine lymphoma patients. Veterinary and Comparative Oncology 2008, 7:92-105.
29. Selting, K.A., Thamm, D.H., 2007. Serum thymidine kinase concentrations in normal versus tumor-bearing dogs. In: Proceedings of the 27th Annual Conference of the Veterinary Cancer Society, Fort Lauderdale, FL, USA, p. 76.
30. Snyder J.M., Shofer F.S., Van Winkle T.J., Massicotte C. Canine intracranial primary neoplasia: 173 cases (1986-2003). Journal of Veterinary Internal Medicine 2006, 20:669-675.
31. Tecles F., Sprianelli E., Bonfanti U., Ceron J.J., Patrinieri S. Preliminary studies of serum acute-phase protein concentration in hematologic and neoplastic diseases of the dog. Journal of Veterinary Internal Medicine 2005, 19:865-870.
32. Tyler J.W., Villamil J.A. Cancer epidemiology and statistics. Cancer Management in Small Animal Practice 2010, 28-34. Elsevier, St. Louis, MO, USA. C.J. Henry, M.L. Higginbotham (Eds.).
33. US Preventive Services Task Force Screening for breast cancer: US Preventive Services Task Force recommendation statement. Annals of Internal Medicine 2009, 151:716-726.
34. Von Euler H.P., Ohrvik A.B., Eriksson S.K. A non-radiometric method for measuring serum thymidine kinase activity in malignant lymphoma in dogs. Research in Veterinary Science 2006, 80:17-24.
35. Von Euler H.P., Rivero P., Aronsson A.-C., Bengtsson C., Hansson L.-O., Eriksson S.K. Monitoring therapy in canine malignant lymphoma and leukemia with serum thymidine kinase 1 activity - evaluation of a new, full automated non-radiometric assay. International Journal of Oncology 2008, 34:505-510.
36. Vos J.H., Borst G.H., Visser I.J., Soethout K.C., de Haan L., Haffmans F., Hovius M.P., Goedendorp P., de Groot M.A., Prud'homme van Reine F.H., van Soest I.L., Willigenburg A.H., van Woerden M.A., Ziekman P.G. Comparison of clinical and pathological diagnoses in dogs. Veterinary Quarterly 2005, 27:2-10.